BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

470 related articles for article (PubMed ID: 33142021)

  • 1. Thymoma-associated myasthenia gravis: Clinical features and predictive value of antiacetylcholine receptor antibodies in the risk of recurrence of thymoma.
    De Rosa A; Fornili M; Maestri Tassoni M; Guida M; Baglietto L; Petrucci L; Chella A; Melfi F; Lucchi M; Ricciardi R
    Thorac Cancer; 2021 Jan; 12(1):106-113. PubMed ID: 33142021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk Factors for the Exacerbation of Myasthenic Symptoms After Surgical Therapy for Myasthenia Gravis and Thymoma.
    Kato T; Kawaguchi K; Fukui T; Nakamura S; Hakiri S; Nakatochi M; Yokoi K
    Semin Thorac Cardiovasc Surg; 2020 Summer; 32(2):378-385. PubMed ID: 31518701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postthymectomy myasthenia gravis: relationship with thymoma and antiacetylcholine receptor antibody.
    Nakajima J; Murakawa T; Fukami T; Sano A; Takamoto S; Ohtsu H
    Ann Thorac Surg; 2008 Sep; 86(3):941-5. PubMed ID: 18721587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors for developing post-thymectomy myasthenia gravis in patients with thymoma.
    Kim A; Choi SJ; Kang CH; Lee S; Son H; Kim JA; Shin JY; Kim SM; Hong YH; Sung JJ
    Muscle Nerve; 2021 Apr; 63(4):531-537. PubMed ID: 33434360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thymoma pathology and myasthenia gravis outcomes.
    Menon D; Katzberg H; Barnett C; Pal P; Bezjak A; Keshavjee S; Bril V
    Muscle Nerve; 2021 Jun; 63(6):868-873. PubMed ID: 33675078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. No correlation between acetylcholine receptor antibody concentration and individual clinical symptoms of myasthenia gravis: A systematic retrospective study involving 67 patients.
    Wang L; Wang S; Yang H; Han J; Zhao X; Han S; Zhang Y; Lv J; Zhang J; Li M; Ji Y; Zhou S; He X; Fang H; Yang J; Zhang Y; Zhang Q; Gao P; Gao F
    Brain Behav; 2021 Jul; 11(7):e02203. PubMed ID: 34075720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between anti-acetylcholine receptor antibodies and the development of post-thymectomy myasthenia gravis in patients with thymoma: a single-center experience.
    Nabe Y; Hashimoto T; Tanaka K; Fujita Y; Yoshimatsu K; Nemoto Y; Oyama R; Matsumiya H; Mori M; Kanayama M; Taira A; Shinohara S; Kuwata T; Takenaka M; Tashima Y; Kuroda K; Tanaka F
    Gland Surg; 2021 Aug; 10(8):2408-2413. PubMed ID: 34527552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measurement of antiacetylcholine receptor antibody in patients with thymoma without myasthenia gravis complications.
    Sakuraba M; Onuki T; Nitta S
    Jpn J Thorac Cardiovasc Surg; 2001 Dec; 49(12):690-2. PubMed ID: 11808089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Excellent response to therapeutic plasma exchange in myasthenia gravis patients irrespective of antibody status.
    Usmani A; Kwan L; Wahib-Khalil D; Trivedi J; Nations S; Sarode R
    J Clin Apher; 2019 Aug; 34(4):416-422. PubMed ID: 30779438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thymectomy in severe (Myasthenia Gravis Foundation of America classes IV-V) generalized myasthenia gravis: is the game really worth the candle?
    Brascia D; Lucchi M; Aprile V; Guida M; Ricciardi R; Rea F; Comacchio GM; Schiavon M; Marino MC; Margaritora S; Meacci E; Spagni G; Evoli A; Lorenzoni G; De Iaco G; De Palma A; Marulli G
    Eur J Cardiothorac Surg; 2023 May; 63(5):. PubMed ID: 37162377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The association between anti-acetylcholine receptor antibody level and clinical improvement in myasthenia gravis.
    Marcuse F; Brandts L; Moens D; Damoiseaux J; Hochstenbag M; Hoeijmakers JGJ; Maessen JG; De Baets M
    Eur J Neurol; 2022 Apr; 29(4):1187-1197. PubMed ID: 34967067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Robotic thymectomy for thymoma in patients with myasthenia gravis: neurological and oncological outcomes.
    Romano G; Zirafa CC; Ceccarelli I; Guida M; Davini F; Maestri M; Morganti R; Ricciardi R; Hung Key T; Melfi F
    Eur J Cardiothorac Surg; 2021 Oct; 60(4):890-895. PubMed ID: 34263301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors affecting improvement of neurologic status evaluated by Quantitative Myasthenia Gravis Score for patients with thymomatous myasthenia gravis after extended thymectomy.
    Haoshuai Z; Jianyong Z; Lei Y; Bo Z; Xiao J; Zhang X; Chen Z; Chunhua S
    J Transl Med; 2021 Oct; 19(1):413. PubMed ID: 34600541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The predictive value of the presence of different antibodies and thymus pathology to the clinical outcome in patients with generalized myasthenia gravis.
    Nikolic A; Djukic P; Basta I; Hajdukovic Lj; Stojanovic VR; Stevic Z; Nikolic D; Bozic V; Lavrnic S; Lavrnic D
    Clin Neurol Neurosurg; 2013 Apr; 115(4):432-7. PubMed ID: 22770539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The relationship between myasthenia gravis and the different pathological type of thymoma patients' operation and prognosis].
    Zhang Y; Yu L; Jing Y; Ke J
    Zhonghua Wai Ke Za Zhi; 2015 Aug; 53(8):612-6. PubMed ID: 26653963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors predicting remission in thymectomized patients with acetylcholine receptor antibody-positive myasthenia gravis.
    Kim H; Lim YM; Lee EJ; Oh YJ; Kim KK
    Muscle Nerve; 2018 Dec; 58(6):796-800. PubMed ID: 30020542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surgical effect and prognostic factors of myasthenia gravis with thymomas.
    Tian W; Li X; Tong H; Weng W; Yang F; Jiang G; Wang J
    Thorac Cancer; 2020 May; 11(5):1288-1296. PubMed ID: 32189468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subclinical myasthenia gravis in thymomas.
    Marcuse F; Hochstenbag M; Hoeijmakers JGJ; Hamid MA; Damoiseaux J; Maessen J; De Baets M
    Lung Cancer; 2021 Feb; 152():143-148. PubMed ID: 33401082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Refractory post-thymectomy myasthenia gravis with onset at MGFA stage V: a case report.
    Zhou RQ; Li LJ; Wu QC
    J Cardiothorac Surg; 2022 May; 17(1):115. PubMed ID: 35551621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Onset and Evolution of Clinically Apparent Myasthenia Gravis After Resection of Non-myasthenic Thymomas.
    Mineo TC; Tamburrini A; Schillaci O; Ambrogi V
    Semin Thorac Cardiovasc Surg; 2018; 30(2):222-227. PubMed ID: 29522809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.